{
    "sec_cik": "0001578845",
    "sec_company_name": "Allergan plc (Filer)",
    "document_type": "8K",
    "sec_form_header": "Form 8-K",
    "sec_period_of_report": "20170208",
    "sec_filing_date": "20170208",
    "sec_changed_date": "20170208",
    "sec_accepted_date": "20170208071544",
    "sec_index_url": "https://www.sec.gov//Archives/edgar/data/1578845/000114420417006604/0001144204-17-006604-index.htm",
    "sec_url": "https://www.sec.gov//Archives/edgar/data/1578845/000114420417006604/0001144204-17-006604.txt",
    "metadata_file_name": "C:\Users\aaron\OneDrive\Desktop\homework\finance2\SEC-EDGAR-text\output_files_examples\batch_0006\004\AGN_0001578845_8K_20170208_8-K_metadata.json",
    "original_file_name": "file was not saved locally",
    "original_file_size": "23561 chars",
    "document_group": "8-K",
    "section_name": "8-K",
    "section_n_characters": 6124,
    "endpoints": [
        "UNITED STATES  ",
        " 99.1  Press Release of Allergan plc entitled “Allergan Reports Strong 2016 Finish with 7% Increase in GAAP Net Revenues to $3.9 Billion in Fourth Quarter 2016” dated February 8, 2017."
    ],
    "extraction_method": "html",
    "warnings": [],
    "company_description": "AGN",
    "output_file": "C:\Users\aaron\OneDrive\Desktop\homework\finance2\SEC-EDGAR-text\output_files_examples\batch_0006\004\AGN_0001578845_8K_20170208_8-K_excerpt.txt",
    "time_elapsed": 0.0,
    "batch_number": 6,
    "batch_signature": "",
    "batch_start_time": "2023-04-16 22:00:52.115412",
    "batch_machine_id": "DESKTOP-BTCJU5K",
    "section_end_time": "2023-04-16 22:12:48.051083"
}